Is pentosan polysulfate disease modifying in OA?

@article{Higgins1996IsPP,
  title={Is pentosan polysulfate disease modifying in OA?},
  author={G. Higgins},
  journal={Inpharma Weekly},
  year={1996},
  volume={1041},
  pages={9-10}
}
  • G. Higgins
  • Published 1996
  • Medicine
  • Inpharma Weekly
    • There is still considerable scepticism regarding the ability of pharmaceutical drugs to modify the disease processes of osteoarthritis. However, findings from recent studies with pentosan polysulfate [Cartrophen®; Ivax/Arthropharm] appear to suggest that such reparative activity may be possible. The results of a number of animal and clinical trials recently conducted with this agent were presented at the 8th Asia-Pacific League Against Rheumatism Congress [Melbourne, Australia; April 1996]. 
    View on Springer

    Topics from this paper

    Explore Further: Topics Discussed in This Paper